Skip links
Companies
› Switzerland › Polypeptide Group Ag
Company registry profile
Polypeptide Group Ag logo

Polypeptide Group Ag

Private limited company (Ltd.) Active

in

From the registry

Registration details

Registration No.
CHE159266771
Incorporation Date
2021-04-07
Address
Baar, Switzerland
Website
www.polypeptide.com/
Status
Active
Country
Switzerland
Source: Zefix — Swiss Central Business Names IndexRegistry coverage
Registry summary

Company overview

Polypeptide Group Ag is a Private limited company (Ltd.) registered in Switzerland under CHE159266771, and its current status with Zefix — Swiss Central Business Names Index is active. The company was incorporated on 7 April 2021 and lists its registered address as Baar, Switzerland. 1 shareholder is on record for Polypeptide Group Ag, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Zefix — Swiss Central Business Names Index and was last updated on 28 September 2026.

Data Provenance
This record is sourced directly from official government registries, including Zefix — Swiss Central Business Names Index.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

1

Shareholders of Polypeptide Group Ag

One shareholder is currently on record for Polypeptide Group Ag, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing. The largest of these is SCHWAB STRATEGIC TRUST-Schwab International Small-Cap Equity ETF, holding 2.1% — the largest recorded stake. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Data-provider feed — rows as supplied to Zavia for Zefix — Swiss Central Business Names Index, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

Swipe or scroll for more columns

Shareholder Type Holding Source Document
SCHWAB STRATEGIC TRUST-Schwab International Small-Cap Equity ETF 2.1% Zefix — Swiss Central Business Names Index

Officers

5

Directors and officers of Polypeptide Group Ag

The Executive Chair of Polypeptide Group Ag currently on record is Klaus Peter Wilden; five officers are currently on record for Polypeptide Group Ag, filed with Zefix — Swiss Central Business Names Index. Management authority at Polypeptide Group Ag sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Data availability

The register reports 20 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Data-provider feed — rows as supplied to Zavia for Zefix — Swiss Central Business Names Index, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

KP
Klaus Peter Wilden ACTIVE

Residence
🇨🇭 Switzerland
Occupation
Executive Chair

JG
Juan Gonzalez ACTIVE

Residence
🇨🇭 Switzerland
Occupation
Chief Executive Officer

DA
Dorothee Anna Deuring ACTIVE

Residence
🇨🇭 Switzerland
Occupation
Mitglied Des Verwaltungsrates

MS
MICHAEL STAHELI ACTIVE

Residence
🇨🇭 Switzerland
Occupation
Head Of Investor Relations & Corporate Communications

CD
Christina Del Vecchio ACTIVE

Residence
🇨🇭 Switzerland
Occupation
Chief Legal Officer & Corporate Secretary

Group Structure

Group structure of Polypeptide Group Ag

Polypeptide Group Ag sits 4 levels below its ultimate parent, C&P Investors Limited, registered in British Virgin Islands. 2 subsidiaries are recorded beneath it, across 3 jurisdictions. The full chain up to C&P Investors Limited is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Polypeptide Group Ag's own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

  • Polypeptide Laboratories Inc. (United States)
  • Polypeptide Laboratories Holding (Ppl) AB (Sweden)

Data availability

Those 2 subsidiaries span Switzerland, United States, Sweden jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 2 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.

Data-provider feed — rows as supplied to Zavia for Zefix — Swiss Central Business Names Index, including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.

Ultimate HQ
C&P Investors Limited
British Virgin Islands
Polypeptide Laboratories Inc.+ subsidiaries
United StatesUS CA 2665700

Polypeptide Laboratories Holding (Ppl) AB+ subsidiaries
SwedenSE 5564995099

Registry questions

Frequently asked questions

Who owns Polypeptide Group Ag?

One shareholder is currently on record for Polypeptide Group Ag, reflecting the Aktienbuch (share register) maintained under Article 686 of the Swiss Code of Obligations rather than a public filing. The largest of these is SCHWAB STRATEGIC TRUST-Schwab International Small-Cap Equity ETF, holding 2.1% — the largest recorded stake. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is Polypeptide Group Ag's UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for Polypeptide Group Ag is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does Polypeptide Group Ag have on record?

1 shareholder is shown on record for Polypeptide Group Ag.

What is Polypeptide Group Ag's company registration number?

Polypeptide Group Ag's registration number is CHE159266771, filed with Zefix — Swiss Central Business Names Index in Switzerland. Its current status on the register is active.

Is Polypeptide Group Ag still an active company?

Polypeptide Group Ag's status on Zefix — Swiss Central Business Names Index is listed as active.

When was Polypeptide Group Ag incorporated?

Polypeptide Group Ag was incorporated on 7 April 2021, according to Zefix — Swiss Central Business Names Index.

What is Polypeptide Group Ag's registered address?

The registered address on file for Polypeptide Group Ag is Baar, Switzerland.

What legal structure is Polypeptide Group Ag registered as?

Polypeptide Group Ag is registered as a Private limited company (Ltd.) in Switzerland.

Who are the officers/directors of Polypeptide Group Ag?

The Executive Chair of Polypeptide Group Ag currently on record is Klaus Peter Wilden; five officers are currently on record for Polypeptide Group Ag, filed with Zefix — Swiss Central Business Names Index. Management authority at Polypeptide Group Ag sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does Polypeptide Group Ag have a parent company or subsidiaries?

Polypeptide Group Ag sits 4 levels below its ultimate parent, C&P Investors Limited, registered in British Virgin Islands. 2 subsidiaries are recorded beneath it, across 3 jurisdictions. Those 2 subsidiaries span Switzerland, United States, Sweden jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 2 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.

Other companies in Switzerland · Manufacturing

All companies in Switzerland · Manufacturing in Switzerland

This website uses cookies to improve your web experience.